Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced that its key product, MEDIHONEY(TM) Wound & Burn Dressing with Active Leptospermum Honey, has been found in a large randomized controlled clinical trial to significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in chronic wounds. The finding was published in the June 2008 issue of The Journal of Wound Care.
MEDIHONEY Eradicates MRSA From Chronic Venous Ulcers
Previous post: Nursing duo design ward infections calendar
Next post: Increased Efforts By Hospitals To Control MRSA Infection